4th Quarter - Report

TIBER CREEK GROUP for EMD SERONO, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to In Vitro Fertilization (IVF); S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; HR 7667 - Food and Drug Amendments of 2022; Consolidated Appropriations Act, 2023 (PL 117-328), Division FF, Title III - Food and Drug Administration, Subtitle B - Drugs and Biologics and Subtitle F, Chapter 1 - Clinical Trial Diversity and Modernization.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
COREY MALMGREN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7667 (117th), S. 4348 (117th)

Medicare/Medicaid MMM

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act (PL 117-169); Issues relating to Part D pricing reform; issues relating to Medicare Part D and Part B Pricing Reform; Issues related to capping out-of-pocket costs.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
COREY MALMGREN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Issues related to the VA infertility coverage benefit.

LobbyistCovered position, as disclosed
MATTHEW LEFFINGWELL —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.